Influence of Apolipoprotein E Genotype on the Risk of Cognitive Deterioration in Moderate Drinkers and Smokers
- 1 May 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 11 (3) , 280-284
- https://doi.org/10.1097/00001648-200005000-00009
Abstract
We investigated the risk of cognitive deterioration in relation to alcohol consumption and smoking according to the apolipoprotein E (ApoE) polymorphism. The ApoE ε4 allele is an established risk factor for dementia and cognitive impairment. There are also some recent indications that vascular risk factors, including alcohol and tobacco consumption, might play a role in cognition. Our data are from the Epidemiology of Vascular Aging (EVA) study, a prospective study of 1,389 subjects ages 59–71 years at study entry, living the city of Nantes, France, and followed at 4 years after entry. Information on subjects’ alcohol and tobacco consumption was collected from a structured questionnaire on food habits. Cognitive performance was assessed by the Mini-Mental State Examination (MMSE). Cognitive deterioration was defined as a decrease of 3 points or more in the Mini-Mental State Examination between study entry and 4-year follow-up. Drinking was associated with a decreased risk of cognitive deterioration in non-ApoE ε4 carriers, whereas an opposite association was observed in ApoE ε4 carriers. The risk of cognitive deterioration associated with tobacco consumption was also modified according to ApoE genotype, with smokers being at decreased risk of cognitive deterioration among ApoE ε4 allele carriers and at increased risk in noncarriers. The effects of alcohol consumption and smoking on the risk of cognitive deterioration appears to be strongly modified by the presence of ApoE ε4 allele.Keywords
This publication has 19 references indexed in Scilit:
- Risk Estimates of Dementia by Apolipoprotein E Genotypes From a Population-Based Incidence Study: The Rotterdam StudyArchives of Neurology, 1998
- Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's DiseaseNew England Journal of Medicine, 1998
- Apolipoprotein E Phenotype and Cognitive Decline in a Prospective Study of Elderly Community WomenArchives of Neurology, 1997
- Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sampleThe Lancet, 1995
- Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's diseaseAnnals of Neurology, 1995
- Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based studyNeurology, 1994
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's diseaseNeurology, 1993
- Risk Factors for Cerebrovascular Disease as Correlates of Cognitive Function in a Stroke-Free CohortArchives of Neurology, 1993